DNA-dependent protein kinase (DNA-PK) has been shown to take part in cell cycle regulatory signal transduction and in the repair of X-ray-induced DNA double-strand breaks. Functional DNA-PK is furthermore needed for the generation of antigen specificity during lymphocyte maturation. The Ku86 subunit of DNA-PK has been reported to exist in human B lymphocytes in a truncated form capable of binding to broken DNA but lacking the ability to activate the kinase function of DNA-PK. In the present work the Ku70 and Ku86 dimer proteins in T and B lymphocytes from human blood donors were analysed by immunoblotting and were observed apparently to be of full length. Also, nuclear protein extracted from B and non-B lymphocytes displayed DNA-dependent kinase activity. However, a minor fraction of Ku86 in lymphocytes was observed to be truncated with a molecular mass of approx. 70 kDa. ß
Introduction
A set of functionally related proteins with an important role for the cellular response to DNA strand break formation is commonly referred to as DNAdependent protein kinase (DNA-PK), consisting of two DNA-binding subunits (Ku70 and Ku86) mediating activation of the large 465 kDa kinase catalytic subunit [1^4] . DNA-PK has been shown to be part of cell cycle regulatory signal transduction engaging p53 and ATM (ataxia telangiectasia mutated) [5^9], and to be part of the repair of DNA double-strand breaks and UV-induced DNA damage [10^12] . In addition, in human lymphocytes functional DNA-PK is needed for CD40 signalling [13] and for the associated generation of antigen speci¢city during lymphocyte maturation, due to its involvement in V(D)J recombination and possibly also in the class switching of immunoglobulin (Ig) genes [1, 2, 14] .
DNA-PK is constitutively expressed in many human cell types, and some mechanisms for the regulation of its activity are known. The cutting of DNA by RAG (recombination-activating genes) at recombination signal sequences in lymphocytes is thought to be rate limiting for DNA-PK activity during V(D)J recombination [3] . Another possible mechanism for cellular control of DNA-PK activity is Ku proteolysis, since Ku86 has been observed in human B lymphocytes [15] , in late-passage human primary ¢broblasts [16] and in the HL60 human promyeloid cell line [17] to be truncated with an apparent molecular mass of approx. 70 kDa. This carboxy-terminal modi¢cation of Ku86 does not prevent its DNA binding but causes loss of activation of the DNA-PK catalytic subunit [15, 18] . In ¢broblasts this truncation was shown to occur not until a protease was brought into contact with Ku during the in vitro extraction procedure [16] .
In the present work B and non-B lymphocytes were found to have Ku86 protein of apparently full length, and to display similar levels of DNA-dependent kinase activity. However, truncation of Ku86 and a decline in the amount of intact Ku70 protein occurred during in vitro blood incubation.
Materials and methods

Cells
Peripheral blood mononuclear cells were isolated from venous blood of healthy donors by gradient centrifugation (Lymphoprep, Nycomed, Norway). A human B lymphoblastoid cell line was established from peripheral blood by EBV transformation as described [19] .
HeLa cells were from an in-house source and of unidenti¢ed origin. The human epithelial-like tumour line HEp2 was from the American Type Culture Collection (ATCC, Manassas, VA) (CCL23). All cells were cultured in RPMI 1640 (Gibco, UK) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 25 mM HEPES and 12 Wg/ml gentamicin.
Antibodies
Antibodies (Abs) used for Western analysis were polyclonal goat anti-Ku-70 (SC-1486; reactive with a C-terminal epitope corresponding to amino acids 590^608) and anti-Ku-86 (SC-1484; reactive with a C-terminal epitope corresponding to amino acids 710^729) from Santa Cruz Biotechnology (Santa Cruz, CA); anti-Ku86 (P80, Ab-3; clone S10B1; reactive with an N-terminal epitope corresponding to amino acids 8^221) was a mouse monoclonal IgG from Oncogene (Cambridge, MA); HRP-conjugated anti-goat and anti-mouse Ig were from Dako (Denmark). The epitope speci¢cations are as indicated by the manufacturers. Abs used for FACS analysis, anti-HLA-DR FITC and anti-CD3-PE, anti-CD19-FITC and anti-CD5-PE, and the isotypic controls MSIgG1-RD1/MSIgG1-FITC were from BeckmanCoulter. Iron bead-conjugated anti-CD3 and anti-CD19 Abs for magnetic separation of T and B lymphocytes (for positive selection), as well as a kit for isolation of untouched B cells (i.e. for negative selection) containing a cocktail of Abs to non-B mononuclear leucocytes (Abs to CD2, CD4, CD11b, CD16, CD36 and IgE), were from Miltenyi Biotec (Germany).
Extraction of nuclear proteins
Immediately following blood sampling, the peripheral blood mononuclear cells of healthy donors were isolated from venous blood by gradient centrifugation using Lymphoprep. The isolated cells were used directly for extraction of nuclear proteins following a modi¢cation of the procedure of Schreiber et al. [20] . Cytoplasmic protein was removed by lysis of pelleted cells in a neutral pH bu¡er containing 10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.5% NP-40 and a mixture of proteinase inhibitors (Complete, from Roche-Boehringer-Mannheim, Germany). Pelleted cell nuclei were then lysed on ice in a hyperosmolar neutral pH solution with 20 mM HEPES, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA and 10% Complete. Protein concentration was determined spectrophotometrically at 540 nm in 96-well microtitre plates using BCA Protein Assay Reagents (Pierce, IL). All extracts were stored at 370³C.
Isolation of T and B lymphocytes
Peripheral blood mononuclear cells of healthy donors were isolated as described above. Isolation of T and B lymphocytes was done following the recommendations of the manufacturer (Miltenyi Biotec). Brie£y, lymphocytes were washed with PBS and ¢l-tered through a 30 Wm ¢lter. Cells were magnetically labelled with anti-human-CD19-conjugated iron microbeads (20 Wl microbeads per 10 7 cells) for 15 min at 6^12³C. The chromatography procedure was performed with a positive selection column (VS plus) placed in a magnetic ¢eld. For the isolation of B cells, the magnetically labelled CD19 positive cells were retained in the column while the unlabelled cells ran through. The column was rinsed with 4U3 ml PBS (pH 7.2) supplemented with 0.5% BSA and 5 mM EDTA. After removal of the column from the magnetic ¢eld, the magnetically retained CD19 positive cells were eluted with 5 ml of rinsing bu¡er. The T cells were isolated with the same procedure, except for using anti-human-CD3-conjugated iron microbeads. The B lymphocyte negative selection procedure using a CS column included the retention in the magnetic column of PBL reacted with a panel of antibodies to non-B mononuclear leucocytes. A fraction of the isolated cells was analysed for purity by £ow cytometry. The isolated T and B cells were used for preparation of nuclear extract as described above.
Flow cytometry
The purity of the isolated T and B cells was analysed using a Coulter Epics XL-MCL £ow cytometer (Coulter, Hialeah, FL) equipped with a 488 nm argon laser for excitation and ¢lters detecting emission at 515^545 nm (for FITC) and 565^595 nm (for PE). Background auto£uorescence was monitored for each sample by analysing cells labelled with dual colour isotypic non-speci¢c mouse Ig. The mouse Fig. 1 . Purity of isolated B and T lymphocyte subpopulations determined by £ow cytometry. T lymphocytes were positively selected by anti-CD3-conjugated iron beads and then labelled with anti-CD5-PE plus anti-CD19-FITC. For the positive selection of B lymphocytes anti-CD19-conjugated iron beads were used followed by £ow cytometry with anti-HLA-DR-FITC plus anti-CD3-PE. For the negative selection of B lymphocytes a magnetic bead procedure including a cocktail of non-B lymphocyte antibodies was used, followed by £ow cytometry with anti-CD5-PE plus anti-CD19-FITC.
monoclonal Abs were diluted 1/10 in PBS using 5 Wl for staining of 0.5^5U10 6 cells/ml. Isolated cells were incubated with dual colour Abs in the dark for 30 min at 4³C. The purity of the T and B populations was determined using anti-CD19-FITC/anti-CD5-PE and anti-HLA-DR-FITC/anti-CD3-PE conjugated Abs.
Western blot analysis
Fractions of the extracted nuclear protein (10 Wg) were pretreated for 10 min at 70³C before loading onto a NuPAGE 7% Tris-acetate pre-cast gel (1.0 mmU12 wells, from Novex, Groningen, Netherlands) and electrophoresis for 1.5 h, 120 V and then transfer by electroblotting to a polyvinylidene £uoride (PVDF) membrane for 1.5 h, 30 V. A prestained size marker (Novex SeeBlue pre-stained standard) was included in each run. After blocking with bu¡er (TBS containing 0.05% Tween 20 and 1.5% ovalbumin) the membranes were incubated for 1 h at room temperature with the following primary antibodies: mouse anti-Ku86 diluted 1/1000, goat anti-Ku86 diluted 1/2000 and goat anti-Ku70 diluted 1/2000. Subsequently, blots were incubated with HRP-conjugated anti-mouse diluted 1/2000 and HRP-conjugated anti-goat diluted 1/4000 for 1 h at room temperature, under gentle agitation. The blots were developed using the enhanced chemiluminescence method (ECL from Amersham-Pharmacia).
Analysis of DNA-PK cs phosphorylating function
The phosphorylating function of DNA-PK was measured using a synthetic peptide containing a consensus p53 phosphorylation site (EPPLSQEA-FADLWKK; Promega, USA) as substrate. 5 Wg of nuclear protein extract was mixed with 0.1 Wl of [Q-33 P]ATP (1000^3000 Ci/mmol; Amersham-Pharmacia, UK), 0.25 mM ATP and 7.5 Wg of peptide substrate in a HEPES bu¡er (25 mM HEPES pH 7.6, 50 mM KCl, 10 mM MgCl 2 , 0.2 mM EGTA, 1 mM DTT and 4% glycerol) in the presence or absence of 1 Wg of sonicated calf thymus DNA. After incubation at 37³C for 20 min the reactions were stopped with 30% acetic acid and spotted onto squares of phosphocellulose paper (P81, Whatman, Germany). After washing repeatedly with acetic acid (15%) and distilled water, bound radioactivity was determined by liquid scintillation counting. All samples were analysed in triplicate.
Results
Full length Ku in both T and B lymphocytes
Highly enriched T and B lymphocyte subpopulations were isolated by a positive selection procedure including incubation of peripheral blood mononuclear cells with iron microbeads conjugated with anti-CD3 or anti-CD19 followed by magnetic column chromatography (Fig. 1) . In addition, B lymphocytes were isolated with a negative magnetic chromatography procedure, in order to minimize manipulation of the selected cells such as labelling with antibodies and binding to the magnetic column. As determined by £ow cytometry using anti-CD5 and anti-HLADR, respectively, the positive selection strategy yielded a purity of 97.5% for the T lymphocytes and 99.6% for the B lymphocytes. Although the negative selection, as expected, was less e¤cient, it resulted in a cell population with 92.7% CD19 B lymphocytes (i.e. 87.1% plus 5.6% CD5 B-1 lymphocytes), with 1.7% T lymphocytes and some unidenti¢ed cells (Fig. 1) .
Crude nuclear protein preparations were made, separated by denaturing SDS-PAGE and immunoblotted in order to semi-quantitate the cellular content of Ku protein. Both B and T lymphocytes could be observed to contain full length Ku70 and Ku86 protein in the nucleus (Fig. 2a^g) . B and T lympho- Fig. 2 . Full length Ku70 and Ku86 in B and T lymphocytes, followed by incubation-dependent Ku degradation in both B and T lymphocytes. After incubation of the blood at room temperature for the indicated times, the lymphocyte subpopulations were isolated by magnetic bead chromatography using positive and negative selection, as indicated. Nuclear protein was then extracted and immunoblotting performed as indicated with a monoclonal Ab to an amino-terminal Ku86 epitope, polyclonal Ab to a carboxy-terminal Ku86 epitope, and polyclonal anti-Ku70 Ab. The arrow indicates the position of a molecular mass 71 kDa marker. 6 cytes isolated by a positive selection magnetic bead procedure (Fig. 2a^c for B cells, and Fig. 2e^g for T cells), as well as from negative selection of B lymphocytes (Fig. 2d) show no di¡erence in the evidence of full length Ku protein due to lymphocyte type or the type of selection. No di¡erence could be found in the Ku86 full length size between lymphocytes and human cell lines (one B lymphoid line and two epithelial lines) (Fig. 2h) . The monoclonal Ku86 Ab reactive with an amino-terminal epitope revealed one full length Ku86 band and a lower approx. 70 kDa molecular mass band (Fig. 2a,d,e,h) . The fraction of Ku86 protein appearing at this lower molecular mass band was higher in the non-incubated PBL (time 0 h, ¢rst lane, Fig. 2a,d ,e) as compared with both of the B and T lymphocyte populations (time 0 h, third lane, Fig. 2a,e and second lane, Fig. 2d) , and was found to become increased in PBL as well as in both B and T lymphocytes upon incubation of blood for 24^48 h (Fig. 2a,e) . The location of the truncation to the C-terminus was supported by the observation that the goat polyclonal Ab recognizing a C-terminal Ku86 epitope produced only one full length band (Fig. 2b,f) . Similar results for Ku86 truncation were obtained with T and B lymphocytes, and irrespective of the type of selection procedure employed. Some cellular modi¢cation of Ku70 is indicated by the decrease in band intensity observed with anti-Ku70 in protein extracts of cells from incubated blood, although there was no sign of any relatively low molecular mass band with the antiKu70 Ab (Fig. 2c,g ).
DNA-dependent kinase activity in T and B lymphocytes
In order to document the function of the full length Ku heterodimers, the ability of Ku protein to activate the kinasing function of DNA-PK cs was assayed. B lymphocytes were negatively isolated using a depletion column. The purity of B cells was determined with anti-CD5 and anti-CD19 Abs as shown in Fig. 1 . Nuclear protein was extracted and the in vitro DNA-dependent phosphorylation was determined using a synthetic p53 peptide containing a DNA-PK cs -speci¢c phosphorylation site. A clear DNA-dependent incorporation of radiolabelled phosphate was observed in the selected cell popula- 33 P]ATP, was determined. Results from two independent B lymphocyte isolation experiments, each performed with and without addition of dsDNA, are shown. B lymphocytes were isolated by a negative selection magnetic bead procedure. Non-B PBL denotes magnetic bead-labelled PBL remaining in the column after elution of the unlabelled B lymphocytes. PBL refers to the cells not subjected to any magnetic bead separation procedure, and PBL 48 h indicates PBL isolated from blood incubated for 48 h at room temperature. The HEp2 cells were grown under optimal conditions. All samples were analysed in triplicate.
tion containing 92% B lymphocytes. This activity level was similar to that of (i) the epithelial HEp2 line, (ii) non-selected PBL, as well as (iii) the non-B cells bound to the magnetic separation column containing 80% T lymphocytes (£ow cytometry results not shown). Similar results were obtained in two independent experiments, based on blood from two healthy individuals. No DNA-dependent kinase activity could be detected in PBL from 48 h incubated blood (Fig. 3) ; immunoblotting of this PBL nuclear extract showed lack of full length Ku86, but presented a band corresponding to the truncated Ku86 form, indicating that full length Ku86 is needed for this kinase activity (immunoblotting results not shown).
Discussion
Our results con¢rm the previous observation of truncated Ku86 in human B lymphocytes [15] and also extend it by showing that under as yet unde¢ned conditions virtually all Ku86 of B cells can exist as an apparently full length form. The lower migration Ku86 form was seen in non-incubated PBL together with virtual lack of this truncated form in the puri¢ed B and T lymphocytes. This discrepancy may be due to the presence of truncated Ku86 in monocytes. However, our collected experience from analysis of PBL from a large number of healthy individuals suggests no correlation with the size of the monocyte population. Instead, the magnetic bead procedure employed for the isolation of B and T lymphocytes may select for cells being relatively una¡ected by the in vitro handling of the blood, and thus reduce the proportion of cells with truncated Ku86. Furthermore, indicating the similarity between B lymphocytes and other cell types in DNA-PK characteristics, we observed the B lymphocyte full length Ku86 to be functionally equivalent to Ku86 isolated from other cell types, i.e. by demonstrating its capacity to activate the catalytic subunit of DNA-PK.
Our ¢nding of the appearance during in vitro incubation of blood in lymphocytes of truncated Ku86 suggests that the ¢ndings of Muller et al. [15] of a lack of full length Ku86 in B lymphocytes may have been in£uenced by proteolysis during the in vitro procedure of B lymphocyte isolation. Interestingly, it was demonstrated recently that in human primary ¢broblasts, although no truncated Ku86 can be detected in intact cells, the exposure during the protein extraction procedure of cellular Ku86 to a serine protease appearing in late-passage ¢broblasts leads to in vitro Ku86 truncation [13] . Since the degraded forms of Ku86 reported in various cell types by different workers [13,15^17] have not yet been characterized in detail, it is not known whether they are identical to each other or result from a speci¢c proteolytic event. Nevertheless, it may be speculated that the Ku86 truncation observed by us is part of a posttranslational cellular Ku regulatory mechanism, rather than to merely re£ect a general disintegration of lymphocyte protein in vivo and/or in vitro. Certainly, considering the role of DNA-dependent protein kinase (including the Ku subcomponents) in a number of cellular processes including complex signal transduction engaging p53 and ATM in£uencing cell cycle progression and apoptosis [3,5^9] , mechanisms for the control of Ku activity are likely to have evolved in human cells.
In summary, the present work provides evidence of normal Ku protein in human peripheral blood B lymphocytes.
